- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Life Imaging finishes 3-D prototype
Three-dimensional ultrasound developer Life Imaging Systems continues to reach milestones in its relationship with B-K Medical of Copenhagen, Denmark. Life Imaging has developed a prototype that integrates Life's 3-D technology with B-K's ultrasound
Three-dimensional ultrasound developer Life Imaging Systems continues to reach milestones in its relationship with B-K Medical of Copenhagen, Denmark. Life Imaging has developed a prototype that integrates Life's 3-D technology with B-K's ultrasound scanners and transducers. The resulting product allows one system to feature 2-D capabilities with 3-D reconstruction and visualization, according to Life Imaging, based in London, Ontario.
Life plans to deliver the first version of the system to B-K at the beginning of April. Under the terms of the October 1997 agreement signed between the two firms, B-K has worldwide rights to market the technology, which is targeted primarily at urology and surgical applications, according to Life.
With these kinds of collaborative relationships with ultrasound vendors, Life expects to experience substantial revenue growth. The company anticipates sales of $4.5 million (Canadian) in 1999.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Can Radiomics Enhance Differentiation of Intracranial Aneurysms on Computed Tomography Angiography?
September 17th 2024Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
Emerging PSMA Radioligand Therapy Shows Benefits for Metastatic Castration-Resistant Prostate Cancer
September 16th 2024The PSMA-targeted modality 177Lu-PNT2002 improved radiographic progression-free survival by 29 percent in patients with mCRPC in comparison to ARPI therapy, according to new phase 3 trial data presented at the ESMO Congress in Spain.
The Nonexistence of Perfect Balance in Radiology
September 16th 2024In the elusive pursuit of reconciling case volume and having an appropriate number of radiologists, the proverbial windsurfer may fare better than stand-up paddleboarders and daredevil surfers at navigating the waves of the profession.
